Troponin I overexpression inhibits tumor growth, perfusion, and vascularization of Morris hepatoma

Journal of Nuclear Medicine

Volumn 47, Issue 9, 2006, Pages 1506-1514

  Schmidt, Kerstin ^a   Hoffend, Johannes ^a   Altmann, Annette ^a   Kiessling, Fabian ^b   Strauss, Ludwig ^a   Koczan, Dirk ^c   Mier, Walter ^a   Eisenhut, Michael ^b   Kinscherf, Ralf ^a   Haberkorn, Uwe ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Angiogenesis; Gene therapy; Perfusion; PET; Troponin I

Indexed keywords

ALBUMIN GADOTERIC ACID GA 68; GADODIAMIDE; GADOTERIC ACID; RADIOPHARMACEUTICAL AGENT; TROPONIN I; UNCLASSIFIED DRUG; WATER O 15; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC GENE THERAPY; APOPTOSIS; ARTICLE; BLOOD VOLUME; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CAPILLARY DENSITY; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER PERFUSION; MICROARRAY ANALYSIS; MORRIS HEPATOMA; NEOVASCULARIZATION (PATHOLOGY); NON INVASIVE MEASUREMENT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STRESS; TUMOR VASCULARIZATION; UMBILICAL VEIN; UPREGULATION; ANIMAL; CELL SURVIVAL; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; SCINTISCANNING; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; LIVER NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; RECOMBINANT PROTEINS; TROPONIN I;

EID: 33750583164     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Herbst RS, Hidalgo M, Pierson AS, et al. Angiogenesis inhibitors in clinical development for lung cancer. Semin Oncol. 2002;29(1, suppl 4):66-77.
2. Moses MA, Wiederschain D, Wu I, et al. Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci U S A. 1999;96:2645-2650.
3. Feldman L, Rouleau C. Troponin I inhibits capillary endothelial cell proliferation by interaction with the cell's bFGF receptor. Microvasc Res. 2002;63:41-49.
4. Kern BE, Balcom JH, Antoniu BA, Warshaw AL, Fernandez-del Castillo C. Troponin I peptide (Glu94-Leu123), a cartilage-derived angiogenesis inhibitor: in vitro and in vivo effects on human endothelial cells and on pancreatic cancer. J Gastrointest Surg. 2003;7:961-968.
5. Hoffend J, Mier W, Schumacher J, et al. Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo. Nucl Med Biol. 2005;32:287-292.
6. Kiessling F, Heilmann M, Vosseler S, et al. Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging. Int J Cancer. 2003;104:113-120.
7. Schmidt K, Hoffend J, Altmann A, et al. Transfer of the sFLT-1 gene in Morris hepatoma results in decreased growth and perfusion and induction of genes associated with stress response. Clin Cancer Res. 2005;11:2132-2140.
8. Schmidt K, Hoffend J, Altmann A, et al. Angiostatin overexpression in Morris hepatoma results in decreased tumor growth but increased perfusion and vascularization. J Nucl Med. 2006;47:543-551.
9. Haberkorn U, Bellemann ME, Brix G, et al. Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine. Eur J Nucl Med. 2001;28:418-425.
10. Ohtake T, Kosaka N, Watanabe T, et al. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J Nucl Med. 1991;32:1432-1438.
11. Sharp PE. The Laboratory Rat. Boston, MA: CRC Press Boca Raton; 1998.
12. Hoffmann U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med. 1995;33:506-514.
13. Hanford HA, Wong CA, Kassan H, et al. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells. Cancer Res. 2003;63:4275-4280.
14. Kiessling F, Huber PE, Grobholz R, et al. Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy. Invest Radiol. 2004;39:34-44.
15. Sluyter R, Halliday GM. Enhanced tumor growth in UV-irradiated skin is associated with an influx of inflammatory cells into the epidermis. Carcinogenesis. 2000;21:1801-1807.
16. Jones MK, Szabo IL, Kawanaka H, et al. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J. 2002;16:264-266.
17. Legendre H, Decaestecker C, Nagy N, et al. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol. 2003;16:491-504.
18. Ren Y, Tsui HT, Poon RT, et al. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer. 2003;107:22-29.
19. Nguyen MT, Lue H, Kleemann R, et al. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol. 2003;170:3337-3347.
20. Kunz P, Hoffend J, Altmann A, et al. Angiopoietin-2 overexpression in Morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes. J Nucl Med. 2006;47:1515-1524.
21. Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005;8:299-309.
22. Weng LP, Yuan J, Yu Q. Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis. Curr Biol. 1998;8:247-256.
23. Le Poole IC, Yang F, Brown TL, et al. Altered gene expression in melanocytes exposed to 4-tertiary butyl phenol (4-TBP): upregulation of the A2b adenosine receptor 1. J Invest Dermatol. 1999;113:725-731.
24. Ohana G, Bar-Yehuda S, Arich A, et al. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J Cell Physiol. 2001;186:19-23.